Bausch Health Co. Inc. (BHC)
6.56
-0.20 (2.96%)
Upcoming Events
Latest Headlines
Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience
September 2, 2026 7:00 AM - BizWire
Bausch Health's Solta Medical launches Fraxel FTX skin device in Australia
September 1, 2026 8:02 AM - StreetInsider
Bausch Health Announces Availability of Solta Medical's Fraxel FTX® in Australia
September 1, 2026 8:01 AM - PR NewsWire
Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds
September 1, 2026 6:58 AM - BizWire
Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners
August 27, 2026 8:02 AM - PR NewsWire
Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results
August 24, 2026 4:30 PM - BizWire
Form 4 Bausch Health Companies For: Aug 19 Filed by: Lenar Aimee J.
August 20, 2026 4:34 PM - SEC Filing
Form 144 Bausch Health Companies Filed by: Lenar Aimee J.
August 19, 2026 10:12 AM - SEC Filing
A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.
August 18, 2026 12:57 PM - Globe NewsWire
Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners
August 17, 2026 8:00 AM - PR NewsWire
Bausch Health CEO joins Bausch + Lomb board amid reshuffle
August 6, 2026 7:05 AM - StreetInsider
Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board
August 6, 2026 7:04 AM - PR NewsWire
Bausch + Lomb Announces Board of Directors Update, Reaffirms Guidance
August 6, 2026 7:00 AM - BizWire
Increasing unusual call option volume: BHC AGRO KORU RSI WU PTEN SIRI OHI EA
August 3, 2026 5:38 AM - StreetInsider
Form 10-Q Bausch Health Companies For: Jun 30
July 30, 2026 4:12 PM - SEC Filing
Bausch Health Co. Inc. (BHC) Tops Q2 EPS by 23c; updates guidance
July 29, 2026 4:15 PM - StreetInsider
Form 8-K Bausch Health Companies For: Jul 29
July 29, 2026 4:12 PM - SEC Filing
BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE
July 29, 2026 4:05 PM - PR NewsWire
Bausch + Lomb Delivers Broad-Based Second-Quarter Growth, Raises Full-Year 2026 Guidance
July 29, 2026 6:58 AM - BizWire
Form 4 Bausch Health Companies For: Jul 17 Filed by: Lenar Aimee J.
July 20, 2026 4:49 PM - SEC Filing
Form 4 Bausch Health Companies For: Jul 15 Filed by: Lenar Aimee J.
July 17, 2026 4:23 PM - SEC Filing
Bausch + Lomb Launches EyeGility™ Inserter Preloaded IOL Delivery System in the United States
July 16, 2026 7:00 AM - BizWire
Form 4 Bausch Health Companies For: Jul 14 Filed by: LEE STEVEN HYOSIG
July 15, 2026 5:20 PM - SEC Filing
Bausch + Lomb glaucoma eye drop fails Phase 2 trial
July 9, 2026 4:30 PM - StreetInsider
Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate
July 9, 2026 4:30 PM - BizWire
Bausch + Lomb Introduces Orphia™, an AI-Powered Digital Health Platform Built to Return Physicians to Patient Care
July 9, 2026 7:00 AM - BizWire
Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026
July 7, 2026 7:39 AM - PR NewsWire
Bausch + Lomb Will Release Second-Quarter 2026 Financial Results on July 29
July 6, 2026 7:15 AM - BizWire
Form 4 Bausch Health Companies For: Jun 30 Filed by: WECHSLER AMY B
July 2, 2026 4:14 PM - SEC Filing
Form 4 Bausch Health Companies For: Jun 30 Filed by: Paulson John
July 2, 2026 4:12 PM - SEC Filing
Form 4 Bausch Health Companies For: Jun 30 Filed by: LEUNG SANDRA
July 2, 2026 4:10 PM - SEC Filing
Form 8-K Bausch Health Companies For: Jun 26
July 1, 2026 4:23 PM - SEC Filing
Michael Goettler Resigns from Bausch Health's Board of Directors
July 1, 2026 4:15 PM - PR NewsWire
New Bausch + Lomb Data Show that Addressing Dry Eye Symptoms is Associated with Improved Quality of Life, Including Lower Anxiety and Increased Self-Confidence
July 1, 2026 7:00 AM - BizWire
Full Article List
